Cargando…
An order restricted multi‐arm multi‐stage clinical trial design
One family of designs that can noticeably improve efficiency in later stages of drug development are multi‐arm multi‐stage (MAMS) designs. They allow several arms to be studied concurrently and gain efficiency by dropping poorly performing treatment arms during the trial as well as by allowing to st...
Autores principales: | Serra, Alessandra, Mozgunov, Pavel, Jaki, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612618/ https://www.ncbi.nlm.nih.gov/pubmed/35048391 http://dx.doi.org/10.1002/sim.9314 |
Ejemplares similares
-
Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011) -
Factorial versus multi‐arm multi‐stage designs for clinical trials with multiple treatments
por: Jaki, Thomas, et al.
Publicado: (2016) -
Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013) -
Designing multi‐arm multi‐stage clinical trials using a risk–benefit criterion for treatment selection
por: Jaki, Thomas, et al.
Publicado: (2015) -
Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)